Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm cleared for phase 3 trial by US FDA

Nov 3, 2021 at 2:06 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment